Tag: Vertex Pharmaceuticals

  • Monday’s Stocks to Watch: First Solar (NASDAQ:FSLR), Cisco Systems (NASDAQ:CSCO), Chevron (NYSE:CVX), Vertex Pharmaceuticals (NASDAQ:VRTX)

    First Solar (NASDAQ:FSLR) rose 4.1% on Friday to extend gains for a sixth session. The stock rallied 36% during the week, the best performer in the S&P 500, after announcing that its 2014 sales are expected to rise to about $4 billion from $3.3 billion last year. First Solar, Inc. (NASDAQ:FSLR) shares after opening at $70.00 moved to $73.97 on last trade day and at the end of the day closed at $73.37. Company price to sales ratio in past twelve months was calculated as 2.21 and price to cash ratio as 4.14. First Solar, Inc. (NASDAQ:FSLR) showed a positive weekly performance of 35.79%.

    Cisco Systems Inc. (NASDAQ:CSCO) plans to offer cloud computing services, pledging to spend US$1bil (RM3.3bil) over the next two years to enter a market currently led by the world’s biggest online retailer Amazon.com Inc. Cisco Systems, Inc. (NASDAQ:CSCO) shares fell -0.87% in last trading session and ended the day on $21.64. CSCO return on equity ratio is recorded as 14.20% and its return on assets is 8.20%. Cisco Systems, Inc. (NASDAQ:CSCO) yearly performance is 6.97%.

    In Pollution Case, Chevron Corporation (NYSE:CVX) Seeks $32 Million from Plaintiffs’ Lawyer Donziger. Chevron Corporation (NYSE:CVX) shares moved up 0.10% in last trading session and was closed at $115.63, while trading in range of $115.58 – $118.00. Chevron Corporation (NYSE:CVX) year to date (YTD) performance is -6.61%.

    Vertex Pharmaceuticals (NASDAQ:VRTX) EVP Peter Mueller sold 7,500 shares of the company’s stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $78.29, for a total transaction of $587,175.00. Following the completion of the sale, the executive vice president now directly owns 158,750 shares of the company’s stock, valued at approximately $12,428,538. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) weekly performance is -5.73%. On last trading day company shares ended up $73.83. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) distance from 50-day simple moving average (SMA50) is -8.54%. Analysts mean target price for the company is $92.50.